US Broker Ratings

Artivion, Inc. (AORT) Stock Analysis: Healthcare Innovator with a 9.31% Upside Potential

Artivion, Inc. (AORT), a key player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its robust portfolio of innovative products and promising market..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Gem with a 22.4% Revenue Growth

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is a compelling name in the biotechnology sector that has been gaining traction among investors, particularly due to its focus on autoimmune diseases—a field characterized..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 20.70% Potential Upside for Investors

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, has positioned itself as a prominent provider of pharmacy services to long-term care facilities (LTCFs) across the..

Certara, Inc. (CERT) Stock Analysis: Healthcare Innovator with a 7.81% Potential Upside

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, operates within the health information services industry. With a current market capitalization of $2.16 billion, Certara is a formidable..

Merus N.V. (MRUS) Investor Outlook: Analyzing a 20.40% Revenue Growth in the Booming Biotech Sector

Merus N.V. (NASDAQ: MRUS), a clinical-stage immuno-oncology company based in the Netherlands, has been making waves in the biotechnology industry. With a market capitalization of $7.14 billion, Merus focuses on..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Potential 135% Upside in Biotech

Apogee Therapeutics, Inc. (NASDAQ: APGE) is making waves in the biotechnology sector with its cutting-edge approach to treating inflammatory and immunological diseases. As a clinical-stage company, Apogee is drawing attention..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Promising 40.81% Upside in the Healthcare Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) has captured the attention of investors with its innovative approach to spinal disorder treatments and promising financial outlook. With a market capitalization of $2.01 billion,..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 66% Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB) presents an intriguing opportunity for investors within the healthcare sector, particularly those focused on biotechnology. As a prominent player in the Chinese market, Zai Lab..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 58.70% Potential Upside in the Medical Devices Sector

Haemonetics Corporation (NYSE: HAE), a leading player in the medical devices sector, presents an intriguing investment opportunity for those interested in the healthcare industry. With a market capitalization of $2.39..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Unlocking a 21.49% Upside Potential for Investors

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands as a prominent player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a market capitalization of $1.07..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 36% Potential Upside in the Diagnostics & Research Sector

Investors keen on the healthcare sector’s diagnostics and research vertical will find Neogen Corporation (NASDAQ: NEOG) an intriguing prospect, especially given its potential upside of 36.18%. Based in Lansing, Michigan,..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A Closer Look at Its 19.51% Upside Potential

Investors looking to capitalize on growth within the healthcare sector should pay close attention to U.S. Physical Therapy, Inc. (NYSE: USPH). With a market cap of $1.36 billion, this Houston-based..

AtriCure, Inc. (ATRC) Stock Analysis: A Healthcare Innovator with a 43.97% Upside Potential

AtriCure, Inc. (NASDAQ: ATRC), a leader in the medical instruments and supplies industry, is capturing investor attention with a compelling narrative of growth potential and innovation in cardiac surgery solutions...

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Revenue Growth and Promising Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has captured investor attention in the healthcare sector, specifically within the drug manufacturers’ niche. Known for its branded and generic pharmaceutical products, ANI Pharmaceuticals offers..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a 106% Potential Upside in the Biotechnology Sector

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning name in the biotechnology sector, is capturing investor interest with its promising potential upside of 106.04%. This clinical-stage biotechnology company is focused on..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking the 303% Potential Upside for Investors

ImmunityBio, Inc. (NASDAQ: IBRX), a pioneering biotechnology firm based in San Diego, California, has captured investor attention with a staggering potential upside of 303.16%. This promising figure, coupled with its..

Ascentage Pharma Group (AAPG) Stock Analysis: Navigating Challenges with Promising Biotech Innovations

In the vibrant and competitive landscape of biotechnology, Ascentage Pharma Group International (AAPG) has positioned itself as a significant player in the healthcare sector. With a market capitalization of $3.71..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 51.5% Revenue Growth Surge and Future Prospects

Kestra Medical Technologies, Ltd. (KMTS) is garnering attention in the healthcare sector, particularly within the Medical Instruments & Supplies industry. Based in Kirkland, Washington, this U.S.-based company is making waves..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A Healthcare Play with a 14.27% ROE

Pediatrix Medical Group, Inc. (MD), a key player in the healthcare sector, operates within the medical care facilities industry, providing essential specialized care for newborns, expectant mothers, and pediatric patients..

MoonLake Immunotherapeutics (MLTX) Investor Outlook: A 167% Upside Potential in Biotech Innovation

MoonLake Immunotherapeutics (NASDAQ: MLTX), a rising star in the biotechnology sector, has captured investor attention with its promising pipeline of therapies targeting inflammatory skin and joint diseases. Headquartered in Zug,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds